British pharmaceutical giant GlaxoSmithKline and rival Pfizer have agreed to end a lawsuit that alleged Pfizer's respiratory ...
GSK Plc and Pfizer Inc. settled a patent-infringement lawsuit over competing vaccines for RSV, ending the dispute in Delaware ...
shortly after the FDA’s back-to-back approvals for GSK’s RSV shot Arexvy and Pfizer’s rival product Abrysvo. The British pharma claimed that the Pfizer vaccine infringed on four of its ...
Explore how U.S. tariffs and vaccine skepticism may impact GSK plc's profitability. Click for my update as tariffs are ...
GSK is one of the pharma industry's top vaccine producers, giving Affinivax' shot the marketing muscle it will need to challenge Pfizer's Prevnar 13 and Prevnar 20 products – targeting 13 and 20 ...
Bullish option flow detected in GSK (GSK) Pharma with 5,714 calls trading, 4x expected, and implied vol increasing over 5 points to 42.48%. Apr-25 38 calls and 4/4 weekly 37 puts are the most ...
As part of a new series looking at how pharma has responded to the pandemic, Neale Belson, SVP UK & Ireland and general manager for the UK at GSK, tells us that it is “absolutely critical” to ...
In this article, we are going to take a look at where GSK plc (NYSE:GSK ... Trump’s tariffs and their effects on the American pharma sector. Although he was unsure of the intention behind ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results